COVID-19 Vaccine Effectiveness Among Older Adults.
Saved in:
| Title: | COVID-19 Vaccine Effectiveness Among Older Adults. |
|---|---|
| Authors: | Laniece Delaunay C; Epiconcept, Paris, France., Mateo-Urdiales A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Pérez-Gimeno G; Department of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain., O'Reilly K; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Uras M; Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, Paris, France., Erdwiens A; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Mlinaric I; Croatian Institute of Public Health, Zagreb, Croatia., Túri G; National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary., Martínez-Baz I; Instituto de Salud Pública de Navarra, Pamplona, Spain., Meijer A; National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Rodrigues AP; Epidemiology Department, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal., Lazar M; Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania., Latorre-Margalef N; Department Microbiology, Public Health Agency of Sweden, Solna, Sweden., Lucaccioni H; Epiconcept, Paris, France., Verdasca N; Infectious Disease Department, National Institute of Health, Lisbon, Portugal., Bella A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Rafael de la Cruz Lopez MA; Epidemiology Service, Directorate General of Public Health, Castilla-La Mancha, Spain., Kelly E; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Enouf V; Centre National de Référence Virus des Infections Respiratoire, Institut Pasteur Université Paris Cité, Paris, France., Tolksdorf K; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Puzelli S; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Ibáñez Pérez AC; Directorate General of Public Health, Consumer Affaris and Care, La Rioja, Spain., Fitzgerald M; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Masse S; Unite des Virus Emergents, UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA, Marseille, France., Oh DY; Department for Infectious Diseases, Influenza and Other Respiratory Viruses Unit, National Reference Centre for Influenza Viruses, Robert Koch Institute, Berlin, Germany., Kaczmarek M; European Centre for Disease Control and Prevention, Stockholm, Sweden., Bacci S; European Centre for Disease Control and Prevention, Stockholm, Sweden., Kissling E; Epiconcept, Paris, France. |
| Corporate Authors: | VEBIS Primary Care Vaccine Effectiveness Group |
| Source: | JAMA network open [JAMA Netw Open] 2026 Jun 01; Vol. 9 (6), pp. e2619040. Date of Electronic Publication: 2026 Jun 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
